Clinical Trials
45 trialsNCT07124000 2026-05-01
DP-04
AstraZeneca
Recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT05381753 2026-02-11
Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World
CStone Pharmaceuticals
Completed
NCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT06985576 2025-12-18
Long-term Study to Evaluate Safety and Persistence of GF-CART01
GenomeFrontier Therapeutics TW Co., Ltd.
Not yet recruiting
NCT06619275 2025-12-05
INTEREST
iOMEDICO AG
Completed
NCT05812027 2025-11-17
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
Active not recruiting
NCT06115681 2025-07-10
Real-world Study of Dedifferentiated Liposarcoma Patients in China
Boehringer Ingelheim
Completed
NCT06321055 2025-05-20
An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States
Bayer
Completed
NCT05377307 2025-05-13
Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
Pell Bio-Med Technology Co., Ltd.
Recruiting
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT05697198 2025-03-06
PREFER
Labcorp Corporation of America Holdings, Inc
Completed
NCT06272864 2025-02-17
BEGIN
BostonGene
Recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT05236257 2024-12-10
EPI VITRAKVI
Bayer
Completed
NCT06299553 2024-05-22
Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
Incyte Biosciences Italy S.r.l
Recruiting
NCT03837678 2024-03-07
Epithelioid Sarcoma Natural History Study
Ipsen
Completed
NCT06264505 2024-02-28
Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study
Power Life Sciences Inc.
Not yet recruiting
NCT05535283 2024-01-02
Assessing Clinical Trial Experiences of Patients With Osteosarcoma
Power Life Sciences Inc.
Not yet recruiting
NCT04681144 2023-10-26
QOLRAD
Bayer
Completed
NCT06070259 2023-10-06
Insights Into Participating in Studies for Bone Cancer
Power Life Sciences Inc.
Not yet recruiting
NCT06039046 2023-09-15
Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients
Power Life Sciences Inc.
Not yet recruiting
NCT06029465 2023-09-08
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Power Life Sciences Inc.
Not yet recruiting
NCT06029478 2023-09-08
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
Power Life Sciences Inc.
Not yet recruiting
NCT02106858 2023-07-24
StivargaPMS
Bayer
Completed
NCT02367924 2023-06-22
YonSar
PharmaMar, Spain
Completed
NCT00716820 2023-04-06
Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).
Pfizer
Completed
NCT04811833 2023-04-05
GASTROMO
Aesculap AG
Withdrawn
NCT05548179 2023-03-06
Exploring Clinical Trial Experiences of People With Leiomyosarcoma
Power Life Sciences Inc.
Unknown
NCT05400018 2022-06-06
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
Genetron Health
Completed
NCT01933958 2022-04-01
Regorafenib Post-marketing Surveillance in Japan
Bayer
Completed
NCT04935333 2021-09-10
MYOSARCII
Igenomix
Unknown
NCT04214457 2021-09-05
MYOSARC
Igenomix
Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT03058406 2020-04-06
HAL03T
Eisai Inc.
Completed
NCT03071809 2019-08-14
Detection of Tumor DNA in Blood Samples From Patients With Early Stage Cancer and "Healthy Controls"
Lexent Bio, Inc.
Terminated
NCT02113683 2018-06-21
MMS-TM
MedInnovation GmbH
Terminated
NCT00444795 2017-02-01
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene
Pfizer
Completed
NCT01299506 2017-01-20
Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
PharmaMar
Completed
NCT01194284 2017-01-19
Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Takeda
Terminated
NCT02383901 2016-09-05
FORTO
Isofol Medical AB
Completed
NCT00631631 2014-05-14
Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma
Millennium Pharmaceuticals, Inc.
Completed
NCT01459757 2013-06-19
Non-Interventional Retrospective Correlation Of Tumor Mutational Status To Clinical Benefit Of GIST Patients Treated With Sunitinib
Pfizer
Completed
NCT01271959 2012-10-05
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Precision Therapeutics
Terminated
NCT00909142 2012-04-06
BICAM
Bayer
Completed